WHEREAS, NRG Oncology seeks to improve the lives of cancer patients by conducting practice-changing multi-institutional clinical and translational research with emphases on gender-specific malignancies including gynecologic, breast and prostate cancers and on localized or locally advanced cancers of all types; WHEREAS, NRG Oncology anticipates to receive award(s) from the National Institutes of Health (“NIH”) and the National Cancer Institute (“NCI”) to conduct oncology clinical trials; WHEREAS, the Parties desire for Institution to participate in the conduct of the clinical trials;
|Effective start/end date||3/1/14 → 7/31/19|
- NRG Oncology Foundation, Inc. (Agmt Signed 9/5/14)
- National Cancer Institute (Agmt Signed 9/5/14)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.